Research Core Leader for 1/3 CTSA UM1 at Duke University
As of 2032 · Last known relationship
Jennifer Shiunroh Li is a Duke pediatric cardiologist and faculty leader whose work has shaped pediatric drug evaluation, congenital heart outcomes research, and childhood-obesity studies. She graduated with distinction from Stanford University in Chemistry and English in 1983, earned her M.D. from Duke in 1987, and completed pediatric internship, residency, and cardiology fellowship training between 1987 and 1993. She later earned a Duke Master’s Degree in Health Sciences in 2005. At Duke, she served as Chief of Pediatric Cardiology beginning in 2006 and Director of Pediatric Research at the Duke Clinical Research Institute from 2001 to 2015. She is listed as Beverly C. Morgan, M.D., Distinguished Professor of Pediatric Cardiology, Professor of Pediatrics and Medicine, and a DCRI member. Her interests include pediatric hypertension, clinical trials, thrombosis, Pompe disease, and infective endocarditis.
Each topic is linked to its supporting source in Sources.
Training includes Research Core Leader for 1/3 CTSA UM1 at Duke University, Research Co-Mentor for machine learning-enhanced cardiomyopathy prediction in childhood cancer survivors, Principal Investigator for the iPediHeart Interdisciplinary Research Training Program for Pediatric Heart Disease, and Director of Paediatric Research at Duke Clinical Research Institute, plus 12 more records.
Explore education and trainingAs of 2032
As of 2031
As of 2030
As of 2015
As of 2005
As of 1993
As of 1990
As of 1989
As of 1987
As of 1983
As of 2012
As of 2008
As of 2008
As of 2006
As of 1999
Analysis and linkage of large multicenter databases to assess outcomes, quality, and cost in pediatric and congenital cardiac care[11]
Analyzed financial and medical data on 59 drugs tested in children under the pediatric exclusivity provision of the Best Pharmaceuticals for Children Act[13]
Clinical trials in children with heart disease[9]
Enzyme replacement in Pompe disease[9]
Evaluation of drug safety and efficacy in children[11]
Infective endocarditis[9]
Led Duke work funded through the American Heart Association’s Strategically Focused Research Network for children, including research on childhood obesity interventions[14]
From 2017
Pediatric hypertension and hyperlipidemia[9]
Thrombosis in patients with congenital heart disease[9]
Took part in a national study compiling data on myocarditis or pericarditis following COVID-19 vaccination[10]